Particularly interesting is that TRPV-1 ligands, i.e., CPS and n-tert-butylecyclohexanol, are able to alleviate chronic fatigue syndrome's (CFS) symptoms. This evidence concerns the gene TRPV1 and myalgic encephalomeyelitis/chronic fatigue syndrome.